Showing 1011-1020 of 1498 results for "".
Advanced Scleral Lens Evaluation Can Improve Results
https://modernod.com/topics/contact-lenses/advanced-scleral-lens-evaluation-can-improve-results/38091/How and why to use some of the new technologies in this field.A New Dynamic in Health Care?
https://modernod.com/topics/retina/a-new-dynamic-in-health-care/38022/How at-home genetic testing has affected patient encounters with eye care practitioners.What’s Your Dry Eye Acumen?
https://modernod.com/topics/ocular-surface/whats-your-dry-eye-acumen/37903/Dry eye therapeutics that every optometrist should know about.Treatment of Neurotrophic Keratitis With Topical Insulin
https://modernod.com/topics/corneaanterior-segment/treatment-of-neurotrophic-keratitis-with-topical-insulin/38870/A literature review.Best Practices on Referring Patients With Symptomatic Vitreous Opacities
https://modernod.com/mod-issues/supplements-inserts/best-practices-on-referring-patients-with-symptomatic-vitreous-opacities-1/38428/The Near Future in Managing Dry Eye Disease
https://modernod.com/mod-issues/marchapril-2025-supplement/the-near-future-in-managing-dry-eye-disease/38940/A closer look at the biggest challenges in treating DED and what’s in the pipeline.Watch for Keratoconus at All Ages
https://modernod.com/articles/significant-findings/watch-for-keratoconus-at-all-ages/37855/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatRisk Versus Reward
https://modernod.com/mod-issues/supplements-inserts/risk-versus-reward/38499/A virtual roundtable on the importance of incorporating new technologies based on data-driven decisions.Point/Counterpoint: Favored Presbyopia Treatment Options
https://modernod.com/mod-issues/2022-jan-feb/point-counterpoint-favored-presbyopia-treatment-options/39123/With a new correction modality recently approved, will one method stand out from the rest?Targeting the Trabecular Meshwork: Collaborative Glaucoma Care
https://modernod.com/topics/glaucoma/targeting-the-trabecular-meshwork-collaborative-glaucoma-care/38154/